TrialCancer science2020

Phase II trial of pazopanib in patients with metastatic or unresectable chemoresistant sarcomas: A Japanese Musculoskeletal Oncology Group study.

Hiroshi Urakawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.